Gene · 389421
NIH grants1,664
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,664
Download this page as JSON| Grant | Title | LIN28B papers | Newest fiscal year |
|---|---|---|---|
| R01AR050631 | The role of microRNAs in cartilage homeostasis and osteoarthritis arthritis treatment | 2 | 2021 |
| R01CA205944 | Characterization of the Role of ADAR1 in Oncogenic Transformation of Progenitors | 2 | 2021 |
| R01HG007175 | DECODING THE IMPACT OF TRANSPOSABLE ELEMENTS ON GENE REGULATION | 2 | 2021 |
| R21CA237939 | Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax | 2 | 2021 |
| R24ES028507 | Enriching the Rhode Island Child Health Study | 2 | 2021 |
| R35CA197706 | Cancer Gene Discovery to Identify Targetable Targets | 2 | 2021 |
| T32GM080178 | Training Program on Genetic Variation and Human Phenotypes | 2 | 2021 |
| T32GM099608 | Predoctoral Training in Pharmacological Sciences | 2 | 2021 |
| U01AI131348 | Roles for DevelopmentallyRegulated microRNAs in Neonatal Immunity | 2 | 2021 |
| U01HG009391 | Connecting transposable elements and regulatory innovation using ENCODE data | 2 | 2021 |
| U24ES026699 | The WashU TaRGET Environmental Epigenomics Data Coordination Center | 2 | 2021 |
| F31DK122649 | Elucidating mechanisms of hnRNPs in fetal hemoglobin regulation | 1 | 2021 |
| I01BX002452 | Kinetic Barriers of Transdifferentiation | 1 | 2021 |
| I01BX003420 | Molecular Impact of Platinum Drugs on the Proteasome and SQSTM1_P62 Complexes_A Paradigm Shift in Resistance | 1 | 2021 |
| K01DK121861 | Role of noncoding RNA decay in glucose homeostasis | 1 | 2021 |
| K08AI128007 | Intrauterine sex steroids and human fetal T cell development | 1 | 2021 |
| K08CA207849 | The role of PLAG1 in Wilms tumor formation | 1 | 2021 |
| K08HL136894 | Hedgehog Signaling in the Progression of Myelodysplastic Syndromes | 1 | 2021 |
| K08NS099427 | Targeting ATRX-Deficient Pediatric GBM | 1 | 2021 |
| K99DK120925 | Roles of BCL11A in γ-globin repression | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/grants?page=27